Atillasoy Ercem 4
4 · Allovir, Inc. · Filed Apr 4, 2022
Insider Transaction Report
Form 4
Allovir, Inc.ALVR
Atillasoy Ercem
See Remarks
Transactions
- Award
Stock Option (Right to Buy)
2022-01-18+56,744→ 56,744 totalExercise: $9.15Exp: 2032-01-18→ Common Stock (56,744 underlying) - Award
Common Stock
2022-01-18+23,256→ 123,603 total
Footnotes (2)
- [F1]The shares reported in this transaction represent Restricted Stock Units ("RSUs") issued under the AlloVir, Inc. 2020 Stock Option and Grant Plan (the "Plan"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. 25% of the RSUs shall vest on January 18, 2023, with the remainder vesting in twelve equal quarterly installments thereafter.
- [F2]25% of this option shall vest and become exercisable on January 18, 2023, with the remainder vesting in twelve equal quarterly installments thereafter.